Fabrizio Amoruso

Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—<scp>IL PSO</scp> (<scp>Italian landscape psoriasis</scp>)

Alessandra Narcisi, Mario Valenti, Luigi Gargiulo et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 44 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis)

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli et al. · Frontiers in Medicine · 2023 · 27 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years

Cataldo Patruno, Gabriella Fabbrocini, Giuseppe Lauletta et al. · Journal of Dermatological Treatment · 2023 · 24 citations · Full text

Medicine, Dermatology, Pediatrics +13

Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS)

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli et al. · Journal of Clinical Medicine · 2024 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)

Luigi Gargiulo, Luciano Ibba, Ruggero Cascio Ingurgio et al. · Journal of Dermatological Treatment · 2024 · 21 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15